Home » Topics » Regulatory

Regulatory
RSS

FDA approves Ferring's degarelix for advanced prostate cancer

Dec. 30, 2008

FDA approves Latisse for hypotrichosis of eyelashes

Dec. 30, 2008

FDA approves Novartis' Gleevec for recurrence following surgical removal of a GIST

Dec. 30, 2008

FDA approves Mozobil to mobilize hematopoietic stem cells in transplantation

Dec. 17, 2008

FDA approves Abbott's Trilipix for patients with mixed dyslipidemia

Dec. 17, 2008

Stelara approved in Canada for moderate to severe plaque psoriasis

Dec. 17, 2008

FDA approves Pegintron/Rebetol combination in pediatric HCV patients

Dec. 16, 2008

FDA approves Lusedra for sedation in diagnostic or therapeutic procedures

Dec. 15, 2008

FDA approves tapentadol immediate-release tablets for acute pain

Nov. 24, 2008

Pirfenidone approved in Japan for idiopathic pulmonary fibrosis

Oct. 20, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...